Hypotensive Anaesthesia (Controlled/Deliberate Hypotension)

Definition

• Morgan & Mikhail's Clinical Anesthesiology, 7e, p. 475

Goals and Advantages

1. Reduced intraoperative blood loss - less transfusion requirement
2. Improved surgical field visibility - especially in confined anatomical spaces (sinuses, ear, skull base)
3. Shorter operating time in many cases
4. Reduced need for allogenic blood transfusion and its associated risks

Target Blood Pressure

• Healthy young adults: Mean arterial pressure (MAP) as low as 50-60 mmHg is generally tolerated without complications
• Chronically hypertensive patients: Autoregulation of cerebral blood flow is shifted - MAP should not drop more than 20-30% below baseline
• ENT/sinus surgery: Maintain systolic MAP of approximately 90 mmHg, best achieved by keeping heart rate around 60 bpm
• Patients with TIA history may not tolerate any reduction in cerebral perfusion
• Morgan & Mikhail's Clinical Anesthesiology, 7e, p. 476
• Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol 1, p. 1120

Physiological Basis

• Reducing HR (beta-blockade, high-dose opioids)
• Reducing SV (neuraxial block, hypovolaemia - not recommended)
• Reducing SVR (vasodilators, volatile agents)
• Reducing venous return (positioning, positive-pressure ventilation)

Techniques and Methods

1. Positioning

• Elevation of the surgical site selectively reduces local blood pressure at the wound
• Reverse Trendelenburg position is recommended for sinus and ENT surgery - optimizes the surgical field by reducing venous pressure

2. Neuraxial Anaesthesia

• Spinal or epidural anaesthesia causes sympathetic blockade, reducing both SVR and venous return
• Effective for lower limb and pelvic surgery

3. Positive-Pressure Ventilation

• Increased intrathoracic pressure impedes venous return, reducing cardiac output and MAP

4. Pharmacological Agents

Note on volatile agents vs. TIVA: Evidence for sinus surgery suggests that volatile agents achieving hypotension by reducing SVR can paradoxically cause vasodilation of nasal microvasculature and worsen the surgical field. A combination of low-dose sevoflurane + remifentanil or TIVA with propofol + remifentanil is generally preferred. BIS monitoring is recommended with TIVA to avoid awareness.

• Scott-Brown's Otorhinolaryngology, Vol 1, p. 1120
• Miller's Anesthesia, 10e; Morgan & Mikhail's, 7e, p. 476

Indications (Procedures Commonly Benefiting)

• Cerebral aneurysm repair (to reduce transmural pressure and risk of rupture)
• Brain tumour resection
• Functional endoscopic sinus surgery (FESS)
• Total hip arthroplasty / major orthopaedic surgery
• Radical neck dissection / thyroidectomy (mild hypotension; reversed before completion)
• Major spine surgery
• Radical cystectomy
• Stapes surgery (otosclerosis) - reduces bleeding in microscopic ear surgery
• Skull base surgery / acoustic neuroma resection
• Vascular procedures where large venous sinus perforations require haemostasis

Contraindications (Relative)

• Morgan & Mikhail's Clinical Anesthesiology, 7e, p. 475

Complications

Complications are more likely in patients with coexisting anaemia. Patients in the beach chair or sitting position are at particular risk for cerebral hypoperfusion. The use of controlled hypotension is declining as evidence emerges that the lower limit of cerebral autoregulation may be at a much higher MAP than previously assumed.

• Morgan & Mikhail's Clinical Anesthesiology, 7e, p. 476
• Miller's Anesthesia, 10e

Monitoring During Controlled Hypotension

• Intra-arterial blood pressure monitoring - mandatory; transducer zeroed at the level of the external auditory meatus (circle of Willis level) to accurately reflect cerebral perfusion pressure
• Cerebral oximetry (NIRS) - recommended when hypotensive techniques are employed
• BIS monitoring - recommended when TIVA is used (to prevent awareness)
• Standard ECG, SpO2, ETCO2, urine output
• Morgan & Mikhail's Clinical Anesthesiology, 7e, p. 476

Recent Evidence (2021-2024)

1. A 2024 British Journal of Anaesthesia systematic review and meta-analysis (Dauterman et al.) examined the efficacy and safety of intraoperative controlled hypotension across randomised trials. [PMID: 39003203]
2. A 2023 meta-analysis (Xu et al., PLoS One) compared dexmedetomidine vs. remifentanil for controlled hypotension under general anaesthesia, supporting dexmedetomidine as an effective alternative. [PMID: 36649357]
3. A 2023 meta-analysis (Munhall et al., Am J Otolaryngol) specifically reviewed dexmedetomidine for controlled hypotension in middle ear surgery, supporting its efficacy and safety in this setting. [PMID: 37163960]

Summary Points

• Hypotensive anaesthesia is a deliberate, controlled reduction in MAP to improve surgical conditions and reduce blood loss
• MAP 50-60 mmHg is the general lower limit in healthy patients; hypertensive patients should not exceed 20-30% reduction below baseline
• Arterial line is mandatory; zeroed at the level of the circle of Willis
• Remifentanil-based TIVA or sevoflurane + remifentanil combinations are preferred over pure volatile anaesthesia for ENT surgery to avoid nasal vasodilatation
• Dexmedetomidine is an emerging agent with growing evidence, especially for ear surgery
• Use is declining overall due to recognition of higher-than-assumed autoregulatory thresholds and risk of ischaemic complications
• Risks and benefits must be discussed with both patient and surgeon prior to use